Novo Nordisk A/S - Total number of voting rights and share capital in Novo Nordisk A/S as of 28 April 2017


Bagsværd, Denmark, 28 April 2017 - In accordance with Section 10 of the Danish Statutory Order on Issuers' Disclosure Obligations, Novo Nordisk is required to publish the total number of voting rights and the size of the share capital in Novo Nordisk A/S as per the end of a month where changes therein have occurred.

Further information

Media:    
Anne Margrethe Hauge +45 3079 3450 amhg@novonordisk.com

Investors:
   
Peter Hugreffe Ankersen +45 3075 9085 phak@novonordisk.com
Hanna Ögren +45 3079 8519 haoe@novonordisk.com
Anders Mikkelsen +45 3079 4461 armk@novonordisk.com
Kasper Veje (US) +1 609 235 8567 kpvj@novonordisk.com

Attachments

Company announcement No 31 / 2017